Search Results - shelby+yuhas

1 Results Sort By:
Novel selective, covalent inhibitors of DNA polymerase beta, and synthetic lethality in BRCA-deficient cancer
Unmet Need / Invention Novelty: Poly(ADP-ribose) polymerase 1 (PARP1) inhibitors are known synthetic lethal partners for breast cancer gene (BRCA) 1- and 2-deficient cancers. However, not all BRCA-deficient cancers are susceptible to PARP1 inhibitors and others develop resistance. Furthermore, DNA polymerase beta is overexpressed in many cancers, decreasing...
Published: 9/27/2024   |   Inventor(s): Marc Greenberg, Shelby Yuhas
Keywords(s):  
Category(s): Clinical and Disease Specializations > Oncology > Breast Cancer, Technology Classifications > Therapeutic Modalities > Targets
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum